The FDA notified doctors of the potential for atrial fibrillation with Reclast. Also mentioned in the NEJM study, there is a small risk of contracting osteonecrosis of the jaw. If you are concerned about this discuss it with your health provider and also your oral surgeon or dentist, to evaluate your risks versus benefits. The most common side effect is flu-like symptoms, fever, headache, and joint or muscle pain. The links below explain the adverse events related to Reclast seen in some individuals.
FDA alert on atrial fibrillation.
http://www.fda.gov/cder/drug/early_comm/bisphosphonates.htm
FDA alert on bisphosphonate joint pain.
http://www.fda.gov/cder/drug/infopage/bisphosphonates/default.htm
American Dental Association's warning on osteonecrosis of the jaw.
http://www.ada.org/prof/resources/topics/osteonecrosis.asp
Novartis offers a yearly reminder service, for women on the go. You can sign up for this reminder service at www.MeetReclast.com.
Need help finding an infusion center? Call 1-866-Reclast or visit www.reclast.com
If you don't have insurance log on to www.pap.novartis.com or call 1-800-245-5356 (Novartis, 2008, Patient Safety Guide).
- Font size
- Email This
- Bookmark
- Thank you for your input
- Save
- RSS
- Report Abuse










